235980 — Medpacto Cashflow Statement
0.000.00%
- KR₩111bn
- KR₩56bn
Annual cashflow statement for Medpacto, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -25,352 | -17,040 | -35,753 | -35,325 | -20,140 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -66.5 | -9,472 | 1,085 | 7,784 | -1,009 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 600 | -365 | 3,189 | -593 | 3,048 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -23,382 | -25,153 | -29,614 | -26,301 | -16,559 |
Capital Expenditures | -811 | -909 | -925 | -173 | -323 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 26,940 | -76,858 | 26,688 | 96,699 | -39,915 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 26,129 | -77,766 | 25,763 | 96,526 | -40,237 |
Financing Cash Flow Items | -24.4 | 34 | — | -15 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -60.4 | 101,523 | 2,898 | 2,014 | -844 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,519 | -1,399 | -933 | 72,244 | -57,595 |